Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (288)
ARTG (239)
Prescription medicine registration (18)

Date

2024 (48)
2023 (47)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (17)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Results for "[search-keyword]"

Search

Sponsor content

545 result(s) found, displaying 31 to 40

PREGABALIN GH pregabalin 200 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2024

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PREGABALIN GH pregabalin 75 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2024

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PREGABALIN GH pregabalin 150 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2024

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PREGABALIN GH pregabalin 225 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2024

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PREGABALIN GH pregabalin 100 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2024

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PREGABALIN GH pregabalin 50 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2024

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PREGABALIN GH pregabalin 300 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

27 June 2024

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
RIVAROXABAN LAPL rivaroxaban 2.5 mg tablet blister pack (392150)

4 March 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN LAPL rivaroxaban 2.5 mg tablet blister pack.
RIVAROXABAN LAPL rivaroxaban 15 mg tablet blister pack (392315)

4 March 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN LAPL rivaroxaban 15 mg tablet blister pack.
RIVAROXABAN LAPL rivaroxaban 10 mg tablet blister pack (392312)

4 March 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN LAPL rivaroxaban 10 mg tablet blister pack.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.